Composite endpoints in trials of type-2 diabetes
Author:
Affiliation:
1. Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto ON Canada
2. Janssen A/S; Birkerød Denmark
3. Health economics and Outcomes Research Consultant; Mumbai India
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12226/fullpdf
Reference94 articles.
1. Standards of medical care in diabetes - 2013;ADA;Diabetes Care,2013
2. Some issues with composite endpoints in clinical trials;Chi;Fundam Clin Pharmacol,2005
3. Clinical perspectives on the use of composite endpoints;Cannon;Control Clin Trials,1997
4. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns;Ferreira-González;J Clin Epidemiol,2007
5. Evidence-based urology in practice: composite endpoints;Lavallée;BJU Int,2010
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE;Diabetes Care;2024-03-25
2. Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE);Diabetes Care;2024-01-09
3. Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators;Diabetes Therapy;2023-05-31
4. Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies;Trials;2023-03-13
5. Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis;Diabetes Therapy;2021-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3